Interleukin 28B polymorphism predicts interferon plus ribavirin treatment outcome in patients with hepatitis C virus-related liver cirrhosis: A multicenter retrospective study in Japan.

Shakado, Satoshi; Sakisaka, Shotaro; Okanoue, Takeshi; Chayama, Kazuaki; Izumi, Namiki; Toyoda, Joji; Tanaka, Eiji; Ido, Akio; Takehara, Tetsuo; Yoshioka, Kentaro; Hiasa, Yoichi; Nomura, Hideyuki; Seike, Masataka; Ueno, Yoshiyuki; Kumada, Hiromitsu

Shakado, Satoshi; Sakisaka, Shotaro; Okanoue, Takeshi; Chayama, Kazuaki; Izumi, Namiki; Toyoda, Joji; Tanaka, Eiji; Ido, Akio; Takehara, Tetsuo; Yoshioka, Kentaro; Hiasa, Yoichi; Nomura, Hideyuki; Seike, Masataka; Ueno, Yoshiyuki; Kumada, Hiromitsu.

Afiliação

Shakado S; Department of Gastroenterology and Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan; Division of Advanced Clinical Research for Viral Hepatitis and Liver Cancer, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Hepatol Res ; 44(9): 983-92, 2014 Sep.

Article em En | MEDLINE | ID: mdl-24400682

Palavras-chave

cirrhosis; hepatitis C virus; interferon; interleukin 28B; ribavirin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatol Res Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google